Immunic
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-1.070.910.360.21
Price/Sales ratio
0.060.140.020.03
Earnings per Share (EPS)
$-0.87$1.03$2.62$4.3

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-12.46-5.56-3.33-4.55-0.19-2.15-5.44-2.43-0.28-0.71-0.38-0.38
Price/Sales ratio
N/AN/A21.62KN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
6.083.512.334.730.631.281.501.780.392.290.401.28
Price/Cash Flow ratio
-14.55-5.80-3.81-5.87-0.18-2.62-5.19-2.71-0.68-0.93-0.70-0.70
Price/Free Cash Flow ratio
-14.06-5.54-3.75-5.77-0.18-2.61-5.17-2.71-0.68-0.93-0.70-0.70
Price/Earnings Growth ratio
0.12-1.630.09-47.550.000.020.14-0.06-0.010.01-0.110.02
Dividend Yield
0.79%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/A-28529.70%N/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/A-653447.59%N/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/A-648744.60%N/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/A-648744.60%N/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
2.28%2.55%4.41%1.10%-1.32%0.30%0.13%0.16%-28.14%N/AN/A-1.32%
Return on Assets
-44.10%-58.39%-63.98%-86.24%-276.90%-52.80%-26.18%-66.71%-120.77%-172.40%-94.24%-276.90%
Return On Equity
-48.85%-63.19%-70.09%-104.06%-333.74%-59.67%-27.68%-73%-135.72%-323.56%-98.63%-333.74%
Return on Capital Employed
-51.47%-63.23%-70.48%-105.09%-337.05%-62.89%-30.70%-71.78%-104.19%-335.55%-75.44%-337.05%
Liquidity Ratios
Current Ratio
10.1912.7811.215.655.674.5515.92N/AN/AN/A9.625.67
Quick Ratio
10.1912.7811.215.655.744.6115.529.399.822.129.105.74
Cash ratio
9.9412.5310.945.535.304.1515.177.618.161.888.165.30
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/A-4.64K-2.97K31.97K-9.23K-12.59KN/AN/A-4.64K
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/A335.59157.46383.656.52K17.68K34.62K16.08K20.29K16.76KN/A17.68K
Cash Conversion Cycle
N/AN/A-157.46N/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.11N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.12N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.00N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.01N/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-83.11N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-41.67N/A
Company Equity Multiplier
1.101.081.091.201.201.131.051.091.121.871.121.13
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/A-5.66KN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.031.041.011.011.011.001.001.001.001.001.001.00
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-41.67N/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-114.08N/A
Dividend Payout Ratio
-9.95%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A